Section 151.441 — Definitions.
151.441 DEFINITIONS. Subdivision 1. Scope. As used in sections 151.43 to 151.471, the following terms have the meanings given in this section. Subd. 2. Dispenser. “Dispenser” means a retail pharmacy, hospital pharmacy, a group of chain pharmacies under common ownership and control that do not act as a wholesale distributor, or any other person authorized […]
Section 151.46 — Prohibited Drug Purchases Or Receipt.
151.46 PROHIBITED DRUG PURCHASES OR RECEIPT. It is unlawful for any person to knowingly purchase or receive a prescription drug from a source other than a person or entity licensed under the laws of the state, except where otherwise provided. Licensed wholesale drug distributors and licensed third-party logistics providers shall not dispense or distribute drugs […]
Section 151.461 — Gifts To Practitioners Prohibited.
151.461 GIFTS TO PRACTITIONERS PROHIBITED. It is unlawful for any manufacturer or wholesale drug distributor, or any agent thereof, to offer or give any gift of value to a practitioner. A medical device manufacturer that distributes drugs as an incidental part of its device business shall not be considered a manufacturer, a wholesale drug distributor, […]
Section 151.47 — Wholesale Drug Distributor Licensing Requirements.
151.47 WHOLESALE DRUG DISTRIBUTOR LICENSING REQUIREMENTS. Subdivision 1. Generally. Each manufacturer, repackager, wholesale distributor, and dispenser shall comply with the requirements set forth in United States Code, title 21, section 360eee-1, with respect to the role of such manufacturer, repackager, wholesale distributor, or dispenser in a transaction involving a product. If an entity meets the […]
Section 151.471 — Third-party Logistics Provider Requirements.
151.471 THIRD-PARTY LOGISTICS PROVIDER REQUIREMENTS. Subdivision 1. Generally. Each third-party logistics provider shall comply with the requirements set forth in United States Code, title 21, sections 360eee to 360eee-4, that are applicable to third-party logistics providers. Subd. 2. Licensing. (a) The board shall license third-party logistics providers in a manner that is consistent with United […]
Section 151.35 — Drugs, Adulteration.
151.35 DRUGS, ADULTERATION. A drug shall be deemed to be adulterated: (1) if it consists in whole or in part of any filthy, putrid or decomposed substance; or if it has been produced, prepared, packed, or held under unsanitary conditions whereby it may have been rendered injurious to health, or whereby it may have been […]
Section 151.36 — Drugs, Misbranding.
151.36 DRUGS, MISBRANDING. A drug shall be deemed to be misbranded: (1) if its labeling is false or misleading in any particular; (2) if in package form and not dispensed pursuant to a prescription unless it bears a label containing (a) the name and place of business of the manufacturer, packer, or distributor, (b) a […]
Section 151.361 — Manufacturer Disclosure.
151.361 MANUFACTURER DISCLOSURE. Subdivision 1. After January 1, 1976. The manufacturer, packager, or distributor of any human use legend drug sold, delivered, or offered for sale in the state of Minnesota after January 1, 1976 must have printed on the label on the immediate container of the drug the name and address of the manufacturer […]
Section 151.37 — Legend Drugs; Who May Prescribe, Possess.
151.37 LEGEND DRUGS; WHO MAY PRESCRIBE, POSSESS. Subdivision 1. Prohibition. Except as otherwise provided in this chapter, it shall be unlawful for any person to have in possession, or to sell, give away, barter, exchange, or distribute a legend drug. Subd. 2. Prescribing and filing. (a) A licensed practitioner in the course of professional practice […]
Section 151.375 — Investigational Drug Use.
151.375 INVESTIGATIONAL DRUG USE. Subdivision 1. Title; citation. This section may be cited as the “Right to Try Act.” Subd. 2. Definitions. (a) For the purposes of this section, the following terms have the meanings given them. (b) “Eligible patient” means a patient who meets the requirements in subdivision 3. (c) “Investigational drug, biological product, […]